Advertisement

Referate pp 45-86 | Cite as

Der aktuelle Stand der Klinik der Halslymphknotenerkrankungen

  • D. Collo
Conference paper
  • 12 Downloads
Part of the Verhandlungsbericht der Deutschen Gesellshcaft für Hals-Nasen-Ohrenheilkunde, Kopf- und Hals-Chirurgie book series (VBDG HNO, volume 1986 / 1)

Zusammenfassung

1963 berichteten Lennert und W. Becker in Hauptreferaten vor der Deutschen HNO-Gesellschaft in Berlin über die Lymphknotenerkrankungen. Seit dieser Zeit ist eine kaum überschaubare Fülle weiterer Daten publiziert worden. Für den Hals-Nasen-Ohrenarzt, dem die Aufgabe zukommt, Lymphknotenerkrankungen des Halses zu klären und ggf. zu behandeln oder durch korrekte Entnahme einer Biopsie zur Diagnosestellung beizutragen, werden in diesem Überblick die heute fundiert erscheinenden Erkenntnisse zusammengestellt.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Alexander P, Hamilton-Fairley G (1967) Cellular resistance to tumors. Br Med Bull 23: 86PubMedGoogle Scholar
  2. 2.
    Appelbaum EL, Mantravadi P, Haas R (1982) Lymphoepithelioma of the nasopharynx. Laryngoscope 92: 510Google Scholar
  3. 3.
    Appelbaum FR, Deisseroth AB, Graw RG, Hertig GP, Levine AS, Margrath IT (1978) Prolonged complete remission following high-dose chemotherapy of Burkitt’s lymphoma in relapse. Cancer 41: 1059PubMedGoogle Scholar
  4. 4.
    Anderson M, Klein G, Ziegler JL, Henle W (1976) Association of Epstein-Barr viral genomes with American Burkitt lymphoma. Nature 260: 357Google Scholar
  5. 5.
    Anderson T, Devita VT, Simon RM, Berard CW, Canellos GP (1982) Malignant lymphoma. Prognostic factors and response to treatment of 473 patients at the National Cancer Institute. Cancer 50: 2708PubMedGoogle Scholar
  6. 6.
    Anderson T, Chabner A, Young RC, Berard CW, Devita VT (1982) Malignant lymphoma. The histology and staging of 473 patients at the National Cancer Institute. Cancer 50: 2699PubMedGoogle Scholar
  7. 7.
    Arnold W, Nakazima YB, Wang B, Vosteen KH, Brunner H, Göbel U (1980) Aktuelle Aspekte zur Ätiologie, Diagnostik und Therapie des Nasenrachenraumkarzinoms. HNO 28: 247Google Scholar
  8. 8.
    Baker SR, Wolfe RA (1982) Prognostic factors of nasopharyngeal malignancy. Cancer 49: 163PubMedGoogle Scholar
  9. 9.
    Bar RS, Dekor CJ, Clausen KP, Hurtubise P, Henle W, Hewetsen JF (1974) Fatal infectious mononucleosis in a family. N Engl J Med 290: 363PubMedGoogle Scholar
  10. 10.
    Beck L (1963) Die Scalenusbiopsie. Zur Diagnostik der Boeckschen Sarkoidose und von Tumoren und Erkrankungen des lymphatischen Systems. Z Laryng Rhinol 42: 407Google Scholar
  11. 11.
    Berker H, Culman H, Adler D, Cremer H, Gross R (1983) Erworbenes Immundefektsyndrom ( AIDS ). Dtsch Ärztebl 26: 33Google Scholar
  12. 12.
    Becker A (1955) Die virusbedingten Erkrankungen im HNO-Bereich. Arch Ohr Nas Kehlk Heilk 167: 106Google Scholar
  13. 13.
    Becker W (1963) Die Klinik der Lymphknotenerkrankungen des Halses. Arch Klin Exp Ohr Nas Kehlk Heilk 182: 125Google Scholar
  14. 14.
    Becker W, Herberhold C (1978) Klinik der Krankheiten des zervikalen Lymphknotensystems. In: Berendes J, Link R, Zöllner F (Hrsg) Hals-Nasen-Ohren-Heilkunde in Praxis und Klinik, Bd III, 14. 1. Thieme, StuttgartGoogle Scholar
  15. 15.
    Becker W (1981) Die Behandlung der Halslymphknotenmetastasen. Z Laryngol 63: 317Google Scholar
  16. 16.
    Berard C, O’Conor GT, Thomas LB (1969) Histopathological definition of Burkitt’s tumor. Bull WHO 40: 601Google Scholar
  17. 17.
    Berard C, Jaffe ES, Braglin RC, Mann RB, Nanba K (1978) Immunologic aspects and pathology of the malignant lymphomas. Cancer 42: 911PubMedGoogle Scholar
  18. 18.
    Berard C, Greene HM, Jaffe ES, Magrath IT (1981) A multidisciplinary approach to Non-Hodgkin’s lymphoma. Ann Intern Med 94: 2810Google Scholar
  19. 19.
    Berger R, Bernheim A, Fellons M, Brouet JC (1979) Cytogenetic study of a European Burkitt’s lymphoma cell-line. J Natl Cancer Inst 62: 1187PubMedGoogle Scholar
  20. 20.
    Bertram B, Sesterhenn K, Mödder U (1982) Das nasopharyngeale Karzinom. HNO 30: 235PubMedGoogle Scholar
  21. 21.
    Bonadonna G, Zucali R, Monfardini S, Del Lena M, Uslenghi C (1975) Combination chemotherapy of Hodgkin’s disease with Adriamycin, Bleomycin, Vinblastine and Imidazole carboxamide versus MOPP. Cancer 36: 252Google Scholar
  22. 22.
    Bonadonna G, Lattuada A, Banfi A (1976) Recent trends in the treatment of Non-Hodgkin’s lymphoma. Eur J Cancer 12: 661PubMedGoogle Scholar
  23. 23.
    Bonadonna G, Beretta G, Castellani R, Canetta P, Spinelli P (1977) Current views on surgical staging in planning the treatment of malignant lymphoma. In: Tagnon HJ, Staquet ML (eds) Recent advances in cancer treatment. Raven Press, New York, p 55Google Scholar
  24. 24.
    Bonadonna G, Santoro A, Bonfanti V, Valagussa P (1982) Cyclic delivary of MOPP and ABVD in stage IV Hodgkin’s disease. Cancer Treat Rep 66: 881PubMedGoogle Scholar
  25. 25.
    Bremer K, Brittinger P, Meusers P, Musshoff K (1980) Therapieempfehlung für Non-HodgkinLymphome. Internist 21: 529Google Scholar
  26. 26.
    Brittinger G, König E (1978) Komplikationen und supportive Therapie der Leukämie und malignen Non-Hodgkin-Lymphome. In: Begemann H (Hrsg) Handbuch der Inneren Medizin, Bd II. Springer, Berlin Heidelberg New York, S 6Google Scholar
  27. 27.
    Brittinger G, Musshoff K, Bremer K, Meusers P (1980) Grundlagen und allgemeine Probleme der Therapie der Non-Hodgkin-Lymphome. Internist 21: 493PubMedGoogle Scholar
  28. 28.
    Britton S, Andersson-Aurret M, Gergely P, Henle W, Jondahl M (1978) Epstein-Barr virus and immunity and tissue distribution in a fatal case of infectious mononucleosis. N Engl J Med 298: 89PubMedGoogle Scholar
  29. 29.
    Brunner KW, Nagel GA (1979) Internistische Krebstherapie. Springer, Berlin Heidelberg New YorkGoogle Scholar
  30. 30.
    Burkitt DP (1958) A sarcoma involving the jaws of African children. Br J Surg 46: 2810Google Scholar
  31. 31.
    Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report of the committee on Hodgkin’s disease staging classification. Cancer Res 31: 1860PubMedGoogle Scholar
  32. 32.
    Carlens E (1959) Mediastinoscopy: A method for inspection and tissue biopsy in the superior mediastinum. Dis Chest 36: 343PubMedGoogle Scholar
  33. 33.
    Carlens E, Jepsen 0 (1968) Mediastinoscopy. Otolaryngol Clin North Am 1: 171Google Scholar
  34. 34.
    Centers of Disease Control (1982) Epidemiologic aspects of the current outbreak of Kaposi’s sarcoma and opportunistic infections. N Engl J Med 306: 248Google Scholar
  35. 35.
    Centers of Disease Control (1982) Persistent, generalized lymphadenopathy among homosexual men. Morbidity Mortality Weekly Rep 31: 249Google Scholar
  36. 36.
    Chabner BA, Johnson RE, Young SK, Devita VT (1978) Sequential nonsurgical and surgical staging of Non-Hodgkin’s lymphoma. Cancer 42: 922PubMedGoogle Scholar
  37. 37.
    Chan SH, Day NE, Khor TH, Kunavatnam N, Chia KB (1981) HLA-markers in the development and prognosis of NPC in chinese. Cancer Campaign 5: 205Google Scholar
  38. 38.
    Chang MY, Campbell WG (1975) Fatal infectious mononucleosis. Arch Pathol 99: 185PubMedGoogle Scholar
  39. 39.
    Chong GC, Beahrs OH, Sizemore GW, Woolner LH (1975) Medullary carcinoma of the thyroid gland. Cancer 35: 695PubMedGoogle Scholar
  40. 40.
    Ciobanu N, Andreeff M, Safai B, Koziner B, Mertelsmann M (1983) Lymphoblastic neoplasia in a homosexual man with Karposi’s sarcoma. Ann Intern Med 98: 151PubMedGoogle Scholar
  41. 41.
    Coker DD, Casterline PF, Chambers RG, Jaques DAA (1977) Metastases to lymphnodes of the head and neck from an unknown primary site. Am J Surg 134: 517PubMedGoogle Scholar
  42. 42.
    Cossman J, Berard CW (1980) Histopathology of childhood Non-Hodgkin’s lymphomas. In: Graham-Pole J (ed) Non-Hodgkin’s lymphomas in children. Masson, New YorkGoogle Scholar
  43. 43.
    Crile G (1966) Excision of cancer of the head and neck. J Am Med 47: 1780Google Scholar
  44. 44.
    Curran JW, Lawrence DN, Jaffe HP, Kaplan JE (1984) Acquired immunodeficiency syndrom ( AIDS) associated with transfusions. N Engl J Med 310: 69Google Scholar
  45. 45.
    Devita VT, Serpick A, Carbone PP (1970) Combination chemotherapy in the treatment of advanced Hodgkin’s disease. Ann Intern Med 73: 881PubMedGoogle Scholar
  46. 46.
    Devita VT, Simon RM, Hubbard SM, Young RC, Berard CW, Moxley JH, Frei E, Carbone PP (1980) Curability of advanced Hodgkin’s disease with chemotherapy. Ann Intern Med 92: 587PubMedGoogle Scholar
  47. 47.
    Devita VT, Hellman S, Rosenberg SA (1982) Cancer - Principles and practice of oncology. Lippincott, Philadelphia TorontoGoogle Scholar
  48. 48.
    Diebold J (1984) Acquired immunodeficiency and related syndroms. Pathol Res Pract 179: 124PubMedGoogle Scholar
  49. 49.
    Doerr W (1974) Organpathologie, Bd I. Thieme, StuttgartGoogle Scholar
  50. 50.
    Dold U, Sack H (1980) Praktische Tumortherapie. Die Behandlung maligner Organtumoren und Systemerkrankungen. Thieme, StuttgartGoogle Scholar
  51. 51.
    Domingo J, Chin NW (1983) Lymphadenopathy in a heterogeneous population at risk for the acquired immunodeficiency syndroms ( AIDS ). Am J Clin Pathol 80: 649Google Scholar
  52. 52.
    Draf W, Genschow B (1973) Halslymphknotenmetastasen und okkulter Primärtumor. Arch Klin Exp Ohr-Nas-Kehlk-Heilk 205: 301Google Scholar
  53. 53.
    Engzell U, Jakobson PA, Sigurdson A, Zajicek J (1971) Aspiration biopsy of metastatic carcinoma in lymph-nodes of the neck. Acta Otolaryngol (Stockh) 72: 138Google Scholar
  54. 54.
    Epstein MA, Achong BG (1979) Discovery and general biology of the virus. The Epstein-Barr virus. Springer, Berlin Heidelberg New YorkGoogle Scholar
  55. 55.
    Essers U (1980) Chemotherapie metastasierter solider Tumoren und Hämoblastosen. Enke, StuttgartGoogle Scholar
  56. 56.
    Ey W (1963) Zur Häufigkeit, Ätiologie und Histologie sowie zur alters-und geschlechtsmäßigen Verteilung von Halslymphknotentumoren. Arch Ohr-Nas-Kehlk-Heilk 182: 363Google Scholar
  57. 57.
    Fahey JL, Detels R, Gottlieb M (1982) Immun-cell augmentation in common in healthy homosexual men. N Engl J Med 308: 842Google Scholar
  58. 58.
    Feller AC, Lennert K, Stein H, Bruhn HD, Wuthe HH (1983) Immuno-histology and aetiology of histiocytic necrotizing lymphadenitis. Histopathology 7: 825PubMedGoogle Scholar
  59. 59.
    Fernandez R, Mouradian J, Metroka C, Davis J (1983) The prognostic value of the histopathology in persistent generalized lymphadenopathy in homosexual men. N Engl J Med 309: 185PubMedGoogle Scholar
  60. 60.
    Fierstein JT, Thawley SE (1978) Lymphoma of head and neck. Laryngoscope 88: 582PubMedGoogle Scholar
  61. 61.
    Fisch U (1966) Lymphographische Untersuchungen über das cervikale Lymphsystem. Karger, BaselGoogle Scholar
  62. 62.
    Fischer R, Schaefer HE, Budde R (1982) Die Alterung des lymphatischen Systems. In: Böhnel J, Heinz R, Stacher A (Hrsg) Hämatologie im Alter. Urban and Schwarzenberg, Wien München BaltimoreGoogle Scholar
  63. 63.
    Földi M (1971) Erkrankungen des Lymphsystems. Wittstrock, Baden-BadenGoogle Scholar
  64. 64.
    Friedman-Kien AE, Laubenstein LJ, Rubinstein P, Buimovici-Klein E, Marmor M (1982) Disseminated Karposi’s sarcoma in homosexual men. Ann Intern Med 96: 693PubMedGoogle Scholar
  65. 65.
    Frizzera G, Rosai J, Dehner LP, Spector BO, Kersey JH (1980) Lymphoreticular disorders in primary immundeficiencies. Cancer 46: 692PubMedGoogle Scholar
  66. 66.
    Frommhold W, Gerhardt P (1981) Erkrankungen des Lymphsystems. Thieme, Stuttgart New YorkGoogle Scholar
  67. 67.
    Garwicz S, Landberg T, Akerman M (1974) Malignant lymphomas in children. Acta Paediat Scand 63: 679PubMedGoogle Scholar
  68. 68.
    Gassmann W, Pralle H, Löffler H (1981) Therapieergebnisse des Morbus Hodgkin in den Stadien I und II. Klin Wochenschr 59: 469PubMedGoogle Scholar
  69. 69.
    Glatstein E, Kim H, Donaldson S (1974) Non-Hodgkin’s lymphomas. Cancer 34: 204PubMedGoogle Scholar
  70. 70.
    Glatstein E, Donaldson S, Rosenberg SA, Kaplan HS (1977) Combined modality therapy in malignant lymphomas. Cancer Treatment Rep 61: 1199Google Scholar
  71. 71.
    Goetz O (1980) Mononukleosis infektiosa. In: Bachmann KD, Ewerbeck H, Joppich G (Hrsg) Pädiatrie in Praxis and Klinik, Bd II, 12. 68. Thieme, Stuttgart New YorkGoogle Scholar
  72. 72.
    Goldfarb PM, Herdy MA (1975) The immunologic response of regional lymphocytes in experimental cancer. Cancer 35: 778PubMedGoogle Scholar
  73. 73.
    Goltzman D, Pott JT, Ridgway EC, Maloof F (1974) Calcitonin as a tumormarker. N Engl J Med 290: 1035PubMedGoogle Scholar
  74. 74.
    Gottlieb MS, Schroff R, Schanker HM, Weissman JD (1982) Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men. N Engl J Med 305: 1425Google Scholar
  75. 75.
    Gottlieb MS, Groopman JE, Weinstein WM, Fahey JL, Detels R (1983) The acquired immunodeficiency syndrom. Ann Intern Med 99: 208PubMedGoogle Scholar
  76. 76.
    Gsell HO (1970) Mononucleosis infectiosa. Klin Gegenw 5: 591Google Scholar
  77. 77.
    Guarda LA, Butler JJ, Mansell P, Hersh EM, Reuben J, Newell GR (1983) Lymphadenopathy in homosexual men. Am J Clin Path 79: 559PubMedGoogle Scholar
  78. 78.
    Haagensen CD, Feind CR, Herter FP, Kanetz CA, Weinberg JA (1972) The lymphatics in cancer. Saunders, PhiladelphiaGoogle Scholar
  79. 79.
    Hansen D, Werner H (1971) Karzinommetastasen von Halslymphknoten bei unbekannt gebliebenem Primärtumor. HNO 19: 51PubMedGoogle Scholar
  80. 80.
    Heggie AD, Robbins FC (1969) Natural rubella acquired after birth. Am J Dis Child 118: 12PubMedGoogle Scholar
  81. 81.
    Hehlmann R, Walther B, Zöllner N, Wolf H, Deinhard F, Schmid M (1981) Fatal lymphoproliferation and acute monocytic leukemia like disease following infectious mononucleosis. Klin Wochenschr 59: 477PubMedGoogle Scholar
  82. 82.
    Hellner H (1963) Die Biopsie: Notwendigkeit, Fehler, Grenzen. Chirurg 34: 385PubMedGoogle Scholar
  83. 83.
    Hendrich JW (1967) Occult cancer with cervical lymph node metastasis. In: Conley J (ed) Cancer of the head and neck. Butterworth, WashingtonGoogle Scholar
  84. 84.
    Henle W, Henle G (1973) Epstein-Barr virus-related serology in Hodgkin’s disease. Nat Cancer Inst 36: 79Google Scholar
  85. 85.
    Henle W, Ho HG, Henle G, Kwan H (1973) Antibodies to Epstein-Barr virus-related antigen in nasopharyngeal carcinomas. J Natl Cancer Inst 51: 381Google Scholar
  86. 86.
    Henle G, Henle W (1976) Epstein-Barr virus specific IgA-serumantibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer 17: 1PubMedGoogle Scholar
  87. 87.
    Herberhold C (1968) Über die Biopsie der Scalenuslymphknoten nach Daniels. Med Welt 19: 315Google Scholar
  88. 88.
    Herberman RD, Ortaldo JR (1981) Natural killer cells: Their role in defenses against disease. Science 214: 24Google Scholar
  89. 89.
    Ho HC (1967) Nasopharyngeal carcinoma in Hongkong. Munksgaard, CopenhagenGoogle Scholar
  90. 90.
    Ho HC (1976) Epstein-Barr virus and specific IgA and the IgG-serumantibodies in nasopharyngeal carcinoma. Br J Cancer 34: 655PubMedGoogle Scholar
  91. 91.
    Ho HC (1978) An epidemiologic and clinical study of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 4: 181Google Scholar
  92. 92.
    Ho HC (1978) Stage classification of nasopharyngeal carcinoma. In: De-Thé G, Ito Y (eds) Nasopharyngeal carcinoma. Int Agency for Research on Cancer, Lyon 33Google Scholar
  93. 93.
    Hoppe RT, Rosenberg SA, Kaplan HS, Cox RS (1980) Prognostic factors in pathological stage III Hodgkin’s disease. Cancer 46: 1240PubMedGoogle Scholar
  94. 94.
    Hoppe RT, Coleman CN, Cox RS, Rosenberg SA, Kaplan HS (1982) The management of stage I-II Hodgkin’s disease with irradiation alone of combined modality therapy: The Standford experience. Blood 59: 455Google Scholar
  95. 95.
    Horstmann DM (1971) Rubella: The challenge of its control. J Infect Dis 123: 640PubMedGoogle Scholar
  96. 96.
    Huang AT, Lucas VS, Baughn SG, Cole TB (1980) A trial of outpatient chemotherapy for recurrent head and neck tumors. Cancer 45: 2038PubMedGoogle Scholar
  97. 97.
    Hymes KB, Cheuring T, Greene JB, Prose NS (1981) Kaposi’s sarcoma in homosexual men. Lancet II: 598Google Scholar
  98. 98.
    Imamura M, Keno H, Matsuura A, Kamiya H, Suzuki T, Kikuchi H, Onoe T (1982) An ultra-structural study of subacute necrotizing lymphadenitis. Am J Pathol 107: 2290Google Scholar
  99. 99.
    Jensen OM,Mouridsen HT, Petersen NS (1982) Kaposi’s sarcoma in homosexual men. Lancet I: 1027Google Scholar
  100. 100.
    Jesse H, Fletcher GH (1977) Treatment of the neck in patients with squamous cell carcinoma of the head and neck. cancer 39: 868Google Scholar
  101. 101.
    Joachim HL, Lerner CW, Tapper ML (1983) The lymphoid lesions associated with the acquired immunodeficiency syndrom. Am J Surg Path 7: 543Google Scholar
  102. 102.
    Jones-Williams W (1982) Aetiology of sarcoidosis. Pathol Res Pract 175: 1Google Scholar
  103. 103.
    Kalden JR, Burmester JR, Manger B, Coester CH, Bienzle U (1983) Immunologische Befunde bei homosexuellen Männern mit generalisierter Lymphadenopathie. Klin Wochenschr 61: 1067PubMedGoogle Scholar
  104. 104.
    Kaplan HS (1981) Hodgkin’s disease: Biology, treatment, prognosis. Blood 57: 813PubMedGoogle Scholar
  105. 105.
    Kaplan HS (1972) Therapy of Hodgkin’s disease. Cambridge, MassGoogle Scholar
  106. 106.
    Kikuchi M, Uryu Y (1976) Phagocytic necrotizing lymphadenitis. Med Bull Fukuoka Univ 3: 321Google Scholar
  107. 107.
    Kikuchi M, Yoshizumi T, Nakamura H (1977) Necrotizing lymphadenitis: possible acute toxoplasmic infection. Virchows Arch [A] 376: 247Google Scholar
  108. 108.
    Klepp O, Dahl O, Stenwig JT (1978) Association of Kaposi’s sarcoma and prior immunosuppressive therapy. Cancer 42: 2626PubMedGoogle Scholar
  109. 109.
    Knospe WH, Loeb V, Huguley CH (1975) Biweekly chlorambucil treatment of chronic lymphocytic leukemia. Cancer 33: 558Google Scholar
  110. 110.
    Kornfeld H, van de Stouwe RA, Lange M, Reddy MM, Grieco MI (1982) T-lymphocytes sub-populations in homosexual men. N Engl J Med 307: 729PubMedGoogle Scholar
  111. 111.
    Krigel RL, Laubenstein LJ, Muggia FM (1983) Kaposi sarcoma: in new staging and classification. Cancer Treat Rep 67: 531PubMedGoogle Scholar
  112. 112.
    Kubik S (1973) Anatomie des Lymphsystems. Radiol Clin 42: 243Google Scholar
  113. 113.
    Krüger G, Fischer R (1980) Das maligne Non-Hodgkin-Lymphom: Übersicht der z. Z. gebräuchlichen oder in der Diskussion befindlichen Klassifikationsschemata. Internist 21: 483Google Scholar
  114. 114.
    Krüger G, Papadakis T, Michel R (1984) Spezielle, pathologisch-anatomische Aspekte des AIDS. Z Hautkr 59: 507Google Scholar
  115. 115.
    Leckie WJH, McCormack RJM, Walbaum PR (1963) The case against routine scalene node biopsy in bronchial carcinoma. Lancet I: 853Google Scholar
  116. 116.
    Lee YTN, Spratt JS (1974) Malignant lymphoma. Grune and Stratton, New York LondonGoogle Scholar
  117. 117.
    Leipzig B, Winter ML (1981) Cervical nodal metastases of unknown origin. Laryngoscope 91: 593PubMedGoogle Scholar
  118. 118.
    Lennert K (1964) Pathologie der Halslymphknoten. Springer, Berlin Heidelberg New YorkGoogle Scholar
  119. 119.
    Lennert K, Stein H, Kaiserling E (1975) Cytological and functional criteria for the classification of malignant lymphomata. Br J Cancer [Suppl 2] 31: 29Google Scholar
  120. 120.
    Lennert K, Müller-Hermlink HK (1975) Lymphozyten und ihre Funktionsformen. Verh Anat Ges 69: 19PubMedGoogle Scholar
  121. 121.
    Lennert K, Mohri N (1978) Histopathology and diagnosis of Non-Hodgkin’s lymphoma. Springer, Berlin Heidelberg New YorkGoogle Scholar
  122. 122.
    Lennert K (1981) Histopathologie der Non-Hodgkin-Lymphome. Springer, Berlin Heidelberg New YorkGoogle Scholar
  123. 123.
    Lennert K, Schwere CW, Krüger G (1981) Lymphknotenveränderungen durch Virusinfektionen. In: Dhom G (Hrsg) Verhandlungen der Deutschen Gesellschaft für Pathologie. 65. Tagung. Fischer, Stuttgart New YorkGoogle Scholar
  124. 124.
    Levine PH, Kamaraja LS, Conelly RR, Berard CW, Dorfman RF, Magrath IT, Easton JM (1982) The American Burkitt’s lymphoma registry: Eight years experience. Cancer 49: 1016Google Scholar
  125. 125.
    Lindahl T, Klein G, Reedman BN, Johansson B, Singh S (1974) Relationship between Epstein-Barr virus (EBV)-DNA and the EBN-determined nuclear antigen ( EBNA) in Burkitt’s lymphoma biopsies and other lymphoproliferative malignancies. Int J Cancer 13: 764Google Scholar
  126. 126.
    Lindbergh RD (1972) Distribution of cervical lymph nodes metastasis from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 29: 1446Google Scholar
  127. 127.
    Llewelyn DM, Dorman D (1971) Mycobacterial lymphadenitis. Aust Paediat J 7: 97Google Scholar
  128. 128.
    Lorentz FW (1965) Zur Ätiologie und Diagnostik der akuten Lymphadenitis colli ohne erkennbare Spezifität im Kindes-und Jugendalter. Z Laryngol Rhinol 44: 234Google Scholar
  129. 129.
    Lukes RJ, Craver LF, Hall TC, Rappaport H, Rubin P (1966) Report of the nomenclature committee. Cancer Res 26: 1311Google Scholar
  130. 130.
    Lukes RJ, Collins RD (1974) Malignant lymphoma: A functional approach to the classification of malignant lymphoma. In: Musshoff K (ed) Recent results in cancer research. Springer, Berlin Heidelberg New YorkGoogle Scholar
  131. 131.
    Lukes RJ, Collins RD (1975) New approaches to the classification of the lymphomata. Br J Cancer [Suppl 2] 31Google Scholar
  132. 132.
    Luthardt T (1980) Infektiöse Mononukleose. In: Ewerbeck H (Hrsg) Infektionskrankheiten, Bd 45. Springer, Berlin Heidelberg New YorkGoogle Scholar
  133. 133.
    Maassen W (1968) Mediastinale Endoskopie und Biopsie. Chir Praxis 12: 347Google Scholar
  134. 134.
    Magrath IT (1974) Immunosuppression in Burkitt’s lymphoma. Int J Cancer 13: 839PubMedGoogle Scholar
  135. 135.
    Magrath IT (1974) Burkitt’s lymphoma. Eur J Cancer 10: 83PubMedGoogle Scholar
  136. 136.
    Magrath IT, Freemann CB, Pizzo P, Gadek J, Jaffe E, Santaella M, Hammer C (1980) Characterization of lymphoma-derived cell lines. J Natl Cancer Inst 64: 477PubMedGoogle Scholar
  137. 137.
    Magrath IT (1982) Malignant lymphomas. In: Levine AS (ed) Cancer in the young. Masson, New YorkGoogle Scholar
  138. 138.
    Magrath IT, Benjamin D, Papadopoulos N (1983) Serum monoclonal immunglobuline bands in undifferentiated lymphomas of Burkitt’s and Non-Burkitt’s types. Blood 61: 726PubMedGoogle Scholar
  139. 139.
    Mann WJ (1984) Ultraschall im Kopf-und Halsbereich. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  140. 140.
    Metroka CE, Cunningham-Rundles S, Sonnabend JA, Fernandez RD, Mouradian J (1984) Generalized lymphadenopathy in homosexual men. In: Molander DW (ed) Diseases of the lymphatic system. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  141. 141.
    Million RR, Cassisi NCJ (1984) Management of head and neck cancer. Lippincott, PhiladelphiaGoogle Scholar
  142. 142.
    Modlin RL, Hofman FM, Meyer PR, Vaccaro SA, Ammann AJ (1983) Altered distribution of B- and T-lymphocytes in lymphnodes from homosexual men with Kaposi’s sarcoma. Lancet 11: 768Google Scholar
  143. 143.
    Molander DW (1985) Diseases of the lymphatic system. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  144. 144.
    Müller-Hermlink HK, Gaudecker B (1980) Ontogenese des lymphatischen Systems beim Menschen. Verh Anat Ges 74: 235Google Scholar
  145. 145.
    Musshoff K, Oehlert W, Hamann W, Nuss A (1969) Klinik, Pathologie und Therapie von Patienten mit geheiltem Morbus Hodgkin. Klin Wochenschr 47: 1175Google Scholar
  146. 146.
    Musshoff K (1980) Strahlentherapie der Non-Hodgkin-Lymphome. Internist 21: 502PubMedGoogle Scholar
  147. 147.
    Nkrumah FK, Perkins IV, Biggar RJ (1977) Combination therapy in abdominal Burkitt’s lymphoma. Cancer 40: 1410PubMedGoogle Scholar
  148. 148.
    Old LJ, Boysen EA, Oettgen HF, De Harren E, Geering G (1966) Precipitation antibody in human serus to an antigen present in cultured Burkitt’s lymphoma cells. Proc Natl Acad Sci USA 56: 1699PubMedGoogle Scholar
  149. 149.
    Pallesen G, Hastrup J, Thestrup-Pederson K, Madsen M (1982) Histologic and immunopathologic studies in a case of chronic EBV infection terminating in a Burkitt-like-lymphoma. Scand J Haematol 25: 347Google Scholar
  150. 150.
    Pallesen G, Andersen H, Jensen MK, Philipp P, Hansen NE, Badsberg E (1979) Burkitt’s lymphoma. Ugeskr Laeger 141: 1827PubMedGoogle Scholar
  151. 151.
    Penn J (1981) Depressed immunity and development of cancer. Clin Exp Immunol 46: 459PubMedGoogle Scholar
  152. 152.
    Penman HG (1970) Fatal infectious mononucleosis. J Clin Pathol 23: 765PubMedGoogle Scholar
  153. 153.
    Philip T, Lenoir GM, Brunat-Meutigny (1980) Individualization pathogenetique du lymphome de Burkitt en France. Pediatrie 35: 695Google Scholar
  154. 154.
    Philip T, Bryon PA, Philippe N, Souillet G (1980) Individualization anatomo-clinique du lymphome de Burkitt en France. Pediatrie 35: 677PubMedGoogle Scholar
  155. 155.
    Pileri S, Kikuchi M, Helbron D, Lennert K (1982) Histiocytic necrotizing lymphadenitis without granulocytic infiltration. Virchows Arch 395: 257Google Scholar
  156. 156.
    Poirier P, Cuneo B (1902) Etude speciale des lymphatiques des différentes partie du corps. In: Porier-Charpy P (ed) Poirier P, Cuneo B 4. ParisGoogle Scholar
  157. 157.
    Portlock CS, Rosenberg SA, Glatstein E, Kaplan HS (1978) Impact of salvage treatment on initial relapse in patients with Hodgkin’s disease. Blood 51: 825PubMedGoogle Scholar
  158. 158.
    Portlock CS (1983) “Good-risk” Non-Hodgkin’s lymphomas approaches to management. Semin Hematol 20: 25PubMedGoogle Scholar
  159. 159.
    Purtilo DF (1976) Pathogenesis and phenotypes of an X-linked recessive lymphoproliferative syndrom. Lancet II: 882Google Scholar
  160. 160.
    Purtilo DF (1980) Immunopathology of infectious mononucleosis and other complications of EBV-infections. Pathol Annu 15: 1Google Scholar
  161. 161.
    Purtilo DF (1981) Epstein-Barr virus-induced oncogenesis in immune-deficient individuals. Lancet II: 300Google Scholar
  162. 162.
    Purtilo DF, Sakamoto K, Saemundson A (1981) Documentation of Epstein-Barr virus infection in immunodeficient patients with life threatening lymphoproliferative diseases by clinical, virological and immunopathological studies. Cancer Res 41: 4226PubMedGoogle Scholar
  163. 163.
    Rappaport H, Berard CW, Butler JJ, Dorfman RF, Lukes RJ, Thomas LB (1971) Report of the committee on histopathological criteria contributing to staging of Hodgkin’s disease. Cancer Res 31: 1864PubMedGoogle Scholar
  164. 164.
    Reichert CM, O’Leary TJ, Lerens DL, Simrell CR, Macher AM (1983) Autopsy pathology in the acquired immundeficiency syndrom. Am J Pathol 112: 357PubMedGoogle Scholar
  165. 165.
    Ritz J, Nadler LM, Bahn AK, Notis-Mc Conarty J, Pesando JM, Schlossman SF (1981) Expression of common acute lymphoblastic leukemia antigen by lymphomas of B-cell and T-cell lineage. Blood 58: 648PubMedGoogle Scholar
  166. 166.
    Robinson JE, Smith D, Niederman J (1981) Plasmocytic differentiation of circulating EBV-infected B-lymphocytes during acute infectious mononucleosis. J Exp Med 153: 235PubMedGoogle Scholar
  167. 167.
    Rosenberg SA, Kaplan HS, Glatstein EJ, Portlock CS (1978) Combined modality therapy of Hodgkin’s disease. A report on the Standford trials. Cancer 42: 991Google Scholar
  168. 168.
    Rosenberg SA, Kaplan HS, Hoppe RT, Kushlan P, Horning S (1981) Overview of the rationale and results of Standford randomized trials of the treatment of Hodgkin’s disease 1967–1980. In: Jones SE, Salmon SD (eds) Adjuvant therapy of cancer. Grune and Stratton, New YorkGoogle Scholar
  169. 169.
    Rouvière H (1932) Anatomie des lymphatiques de l’homme. Masson, ParisGoogle Scholar
  170. 170.
    Rouvière H (1938) Anatomy of the human lymphatic system. Tobias, Ann ArborGoogle Scholar
  171. 171.
    Ruskin J, Remington JS (1976) Toxoplasmosis in the compromised host. Ann Intern Med 84: 193PubMedGoogle Scholar
  172. 172.
    Rusznyak I, Földi M, Szabo G (1969) Lymphologie: Physiologie und Pathologie der Lymphgefäße und des Lymphkreislaufes. Fischer, StuttgartGoogle Scholar
  173. 173.
    Santoro A, Bonadonna G, Bonfanti V, Valagussa P (1982) Alternating drug combinations in the treatment of advanced Hodgkin’s disease. N Engl J Med 36: 777Google Scholar
  174. 174.
    Sauer H, Wilmans W (1985) Internistische Therapie maligner Erkrankungen. Urban and Schwarzenberg, München Wien BaltimoreGoogle Scholar
  175. 175.
    Schaadt M, Plaumann L, Diehl V (1984) Diagnostik der Non-Hodgkin-Lymphome. Dtsch Med Wochenschr 109: 221PubMedGoogle Scholar
  176. 176.
    Schaadt M, Plaumann L, Diehl V (1984) Therapie der Non-Hodgkin-Lymphome. Dtsch Med Wochenschr 109: 261PubMedGoogle Scholar
  177. 177.
    Schick P (1975) Lymphozytenkinetik bei lymphatischen Systemerkrankungen. In: Theml H, Begemann H (Hrsg) Lymphozyt und klinische Immunologie. Springer, Berlin Heidelberg New YorkGoogle Scholar
  178. 178.
    Schnetzer J (1966) Die Mediastinoskopie. Wien Med Wochenschr 116: 358PubMedGoogle Scholar
  179. 179.
    Schomberg PJ, Evans RG, O’Connell MJ, White WL, Banks PM (1984) Prognostic significants of mediastinal mass in adult Hodgkin’s disease. Cancer 53: 324PubMedGoogle Scholar
  180. 180.
    Schuller DE, Krause CJ (1978) Spinal accessory lymphnodes. Laryngoscope 88: 439PubMedGoogle Scholar
  181. 181.
    Shumrick DA (1965) A lump in the neck. Gen Pract 31: 110Google Scholar
  182. 182.
    Siegal FR, Lopez C, Hammer CS, Brown AE, Kornfeld SJ, Gold J (1981) Severe acquired immunodeficiency in male homosexual. N Engl J Med 305: 1439PubMedGoogle Scholar
  183. 183.
    Sheel RT (1982) Manual of cancer chemotherapy. Little Brown and Co, BostonGoogle Scholar
  184. 184.
    Slanina J, Wannenmacher M, Mittermayer C, Allgeier G (1979) Zur Prognose der Epipharynxtumoren. Strahlentherapie 155: 529PubMedGoogle Scholar
  185. 185.
    Sohn CC, Schroff RW, Kliewer KE, Lebel DM, Fligiel S (1983) Disseminated mycobacterium avium-intracellulare infection in homosexual men with acquired cell-mediated immunodeficiency. Am J Clin Pathol 79: 247PubMedGoogle Scholar
  186. 186.
    Spector BD, Perry GS, Kersey JH (1978) Genetically determined immunodeficiency diseases and malignancy. Cancer Reg Clin Immunol 11: 12Google Scholar
  187. 187.
    Stein H (1978) The immunologic and immunochemical bases for the Kiel classification. In: Lennert K, Mohri N, Stein H, Kaiserling E, Müller-Hermelink HK (eds) Malignant lymphomas other than Hodgkin’s disease. Springer, Berlin Heidelberg New York, p 529Google Scholar
  188. 188.
    Stobbe H, Petrow Z (1972) Grundsätze der Zytodiagnostik des Lymphknotens. Dtsch GesundhWes 27: 438Google Scholar
  189. 189.
    Sträuli P (1970) The barrier function of lymph nodes. In: Saegesser F (ed) Surgical oncology. Huber, BernGoogle Scholar
  190. 190.
    Sträuli P, Haemmerle G, Lindemann R (1973) Role of regional lymph nodes in spread of cancer. In: Garrattini S (ed) Chemotherapy of cancer dissemination and metastasis. Raven, New YorkGoogle Scholar
  191. 191.
    Suen JY, Myers EN (1981) Cancer of the head and neck. Churchill Livingstone, New York Edinburgh London MelbourneGoogle Scholar
  192. 192.
    Targan S, Dorey F (1980) Interferon activation “prespontaneous killer” cells and alteration in kinetics of lysis of both “pre-SK” and active SK-cells. J Immunol 124: 2157PubMedGoogle Scholar
  193. 193.
    Thalhammer O (1981) Toxoplasmose. Dtsch Med Wochenschr 106: 1051Google Scholar
  194. 194.
    Theml H (1977) Die chronische lymphatische Leukämie. In: Begemann H (Hrsg) Handbuch der Inneren Medizin. Springer, Berlin Heidelberg New YorkGoogle Scholar
  195. 195.
    Thorley-Lawson DA (1980) The suppression of EBV-infection in vitro occurs after infection. J Immunol 124: 745PubMedGoogle Scholar
  196. 196.
    Torti FM, Portlock CS, Rosenberg SA, Kaplan HS (1981) Extralymphatic Hodgkin’s disease. Prognosis and response to therapy. Am J Med 70: 487Google Scholar
  197. 197.
    Treuner J, Niethammer D, Dannecker G, Jobke A, Aldenhoff P (1981) Treatment of nasopharyngeal carcinoma in children with fibroblast interferon. In: Grundmann E, Krueger GRF, Ablashi DV (eds) Nasopharyngeal carcinoma. Fischer, Stuttgart New YorkGoogle Scholar
  198. 198.
    Turner RR, Dorfman RF (1983) Necrotizing lymphadenitis. Am J Surg Pathol 7: 115PubMedGoogle Scholar
  199. 199.
    Uhlenbruck G, Wintzer G (1981) Carcinoembryonales Antigen und andere Tumormarker. Tumordiagnostik, LeonbergGoogle Scholar
  200. 200.
    Urmacher C, Myskowski P, Ochoa M, Kris M, Safai B (1982) Outbreak of Kaposi’s sarcoma with cytomegalovirus infection in young homosexual men. Am J Med 72: 569PubMedGoogle Scholar
  201. 201.
    Vogt M, Bettex JD, Lüthy R (1983) Erworbenes Immundefektsyndrom ( AIDS ). Dtsch Med Wochenschr 108: 1927Google Scholar
  202. 202.
    Volbendring P, Conant MA, Stricker RB, Lewis BJ (1983) Chemotherapy in advanced Kaposi sarcoma. Am J Med 74: 652Google Scholar
  203. 203.
    Wakasa H, Takahashi H, Kimura N (1978) Necrotizing lymphadenitis. Rec Adr RES 18: 85Google Scholar
  204. 204.
    Waterson AP (1983) Regular views: acquired immundeficiency syndrom. Brit Med J 286: 743Google Scholar
  205. 205.
    Wedelin C, Björkholm M, Biberfeld P, Holm G, Johansson B (1984) Prognostic factors in Hodgkin’s diseases with special reference to age. Cancer 53: 1202PubMedGoogle Scholar
  206. 206.
    Wells SA, Baylin SB, Linehan WM, Farrell RE, Cox EB, Cooper CW (1978) Provocative agents and the diagnosis of medullary carcinoma of the thyroid gland. Ann Surg 188: 139PubMedGoogle Scholar
  207. 207.
    Wolinski E (1979) Nontuberculous mycobacterium and associated diseases. Ann Rev Resp Dis 119: 107Google Scholar
  208. 208.
    Zeng Y, Liu YX, Liu CR, Chen SW, Wei NJ, Zhu JS (1980) Application of immunoenzymatic method and immunoautoradiographic method for the mass survey of nasopharyngeal carcinoma. Intervirology 13: 162Google Scholar
  209. 209.
    Zeng Y, Zhang LG, Lee HY, Jan MG, Zhang Q, Wu YC, Wang YS (1982) Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou City, China. Int J Cancer 29: 139Google Scholar
  210. 210.
    Ziegler JL, Magrath IT, Olweny CCM (1979) Cure of Burkitt’s lymphoma. Lancet II: 936Google Scholar
  211. 211.
    Ziegler JL (1981) Burkitt’s lymphoma. N Engl J Med 305: 735PubMedGoogle Scholar
  212. 212.
    Zur Hausen G, Schulte-Holthausen H, Klein G, Henle G, Henle W (1970) EBV-DNA in biopsies of Burkitt’s tumors and anaplastic carcinoma of the nasopharynx. Nature 228: 1056PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • D. Collo
    • 1
  1. 1.Hals-Nasen-Ohrenklinik der UniversitätMainz 1Germany

Personalised recommendations